Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
The clinical research of Xuelian Tongmai Pill on posterior circulation ischemic vertigo dizziness of phlegm turbidity resistance type
Hits 1698  Download times 1435  Received:January 29, 2019  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2019.03.10
Key Words   Xuelian Tongmai Pill;posterior circulation ischemic vertigo;phlegm turbidity resistance type;dizziness
Author NameAffiliationE-mail
CHEN Xiaobing Xinjiang Urumqi Traditional Chinese Medicine Hospital, Urumqi 830000, China  
REN Xiaojuan Xinjiang Urumqi Traditional Chinese Medicine Hospital, Urumqi 830000, China 435053996@qq.com 
ZHANG Xiufen Xinjiang Urumqi Traditional Chinese Medicine Hospital, Urumqi 830000, China  
LIU Yuanyuan Xinjiang Urumqi Traditional Chinese Medicine Hospital, Urumqi 830000, China  
ZHANG Jiajia Xinjiang Urumqi Traditional Chinese Medicine Hospital, Urumqi 830000, China  
Abstract
    [Objective] To observe the clinical efficacy of Xuelian Tongmai Pill in treating posterior circulation ischemic vertigo dizziness(phlegm turbidity resistance type). [Methods] Onehundred and twenty patients who were suffered from posterior circulation ischemic vertigo dizziness (phlegm turbidity resistance type)were randomly divided into the treatment group and the contrast group, which each group concludes 60 patients. The contrast group was treated with Nimodipine tablet, while the treatment group was treated with Nimodipine tablet and Xuelian Tongmai pill.The course of treatment was 8 weeks. The changes in syndrome score, blood flow velocity of the vertebrobasilar artery, and cerebral arteries blood flow index of vertebral artery(VA)and basilar artery(BA)systolic peak flow velocity(Vp), peak diastolic blood flow velocity(Vd)and other indicators of change were evaluated after the treatment. [Results] There was significant difference between the treatment group and the contrast group on vertigo symptom integral scores, total efficiency, TCD, Vm, PI and blood viscosity after the treatment(P<0.05). [Conclusion] XueLianTongMai Pill can not only improve the posterior circulation ischemic vertigo but also relieve symptoms of dizziness. And the mechanism may be that it can alter the average vertebral-basilar artery flow velocity and blood viscosity.

You are the 1750434 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.